1-3 of 3
Richard Byers, PhD, MBChB
Close
Sort by
Journal Articles

Evidence That Activated Hedgehog Signaling Predicts for Poor Clinical Outcome in Acute Myeloid Leukemia

Veronica Campbell, BS, Eleni Tholouli, MD, PhD, M. Travis Quigley, MS, John Keilty, MS, Patrick Kelly, MD, Karen McGovern, PhD, Margaret Read, PhD, Jeffery L. Kutok, MD, PhD, Richard Byers, PhD, MBChB
Journal: Blood
Blood (2012) 120 (21): 1441.
https://doi.org/10.1182/blood.V120.21.1441.1441
Published: 2012
Journal Articles

Combined Targeting of the MET and FGF Receptor Tyrosine Kinases Induces Sustained AML Cell Death by Preventing Compensatory Upregulation of HGF in Response to MET Kinase Inhibition

Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Casie Reed, BS, Scott J. Rodig, MD, PhD, Eleni Tholouli, PhD, MRCPath, Vu Ngo, PhD, Jeffery Lorne Kutok, MD, PhD, Suzanne E. Dahlberg, PhD, Lisa A Moreau, PhD, George Vande Woude, PhD, James Christensen, MD, Richard Byers, PhD, MBChB, FRCPath, Andrew L. Kung, MD, PhD, Louis M. Staudt, MD., Ph.D., Thomas Look, MD
Journal: Blood
Blood (2011) 118 (21): 1405.
https://doi.org/10.1182/blood.V118.21.1405.1405
Published: 2011
Journal Articles

Aberrant Expression of Hepatocyte Growth Factor Induces Autocrine MET Activation Providing a Novel Therapeutic Target In Acute Myeloid Leukemia.

Alex Kentsis, MD, PhD, Takaomi Sanda, MD, PhD, Vu Ngo, PhD, Scott J. Rodig, MD, PhD, Jeffery Kutok, MD, PhD, Eleni Tholouli, PhD, MRCPath, Richard Byers, PhD, MBChB, FRCPath, George Vande Woude, PhD, Andrew L. Kung, MD, PhD, Louis M. Staudt, MD, PhD, A. Thomas Look, MD
Journal: Blood
Blood (2010) 116 (21): 1042.
https://doi.org/10.1182/blood.V116.21.1042.1042
Published: 2010